HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jenny Ye Selected Research

Type 2 Diabetes Mellitus (MODY)

8/2016Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.
9/2014Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.
9/2013Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jenny Ye Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
08/2016 - 09/2013
3Body Weight (Weight, Body)
08/2016 - 09/2013
2Hypoglycemia (Reactive Hypoglycemia)
08/2016 - 09/2013
2Weight Gain
08/2016 - 09/2013
1Overweight
08/2016
1Body Weight Changes
08/2016
1Hyperglycemia
09/2013

Drug/Important Bio-Agent (IBA)

3lixisenatideIBA
08/2016 - 09/2013
2Insulin (Novolin)FDA Link
08/2016 - 09/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2016
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
08/2016
1insulin glulisineFDA Link
08/2016
1Insulin Glargine (Lantus)FDA Link
08/2016
1Glucose (Dextrose)FDA LinkGeneric
09/2014
1Short-Acting InsulinIBA
09/2013
1Glucagon-Like Peptide-1 ReceptorIBA
09/2013
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2013
1Metformin (Glucophage)FDA LinkGeneric
09/2013

Therapy/Procedure

2Therapeutics
08/2016 - 09/2013
1Glycemic Control
09/2013